Primary Sclerosing Cholangitis-Associated Inflammatory Bowel Disease

Fennimore, Blair; Regner, Emilie; Gerich, Mark E.

doi:10.1007/978-3-319-40908-5_3

Cited by 1 publication

(1 citation statement)

References 128 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent study reported a prevalence of 4.03 PSC cases per 100,000 subjects and an incidence of 0.41 PSC per 100,000 person-years in a Caucasian population [2]. Additionally, up to 80% of PSC patients simultaneously suffer inflammatory bowel disease (IBD) [3] and an increased incidence of malignancy, such as intrahepatic cholangiocarcinoma, hepatobiliary cancer, and colorectal cancer [4][5][6][7]. Liver transplantation is the most definitive way for the treatment of PSC as there is no other better proven therapy of PSC to date.…”

Section: Introductionmentioning

confidence: 99%

Gene Set Enrichment Analysis Detected Immune Cell-Related Pathways Associated with Primary Sclerosing Cholangitis

Luo

Liu

Hou

et al. 2022

BioMed Research International

View full text Add to dashboard Cite

Aim. To explore various immune cell-related causal pathways for primary sclerosing cholangitis (PSC). Methods. Immune cell-related pathway association study was conducted via integrative analysis of PSC GWAS summary and five immune cell-related eQTL datasets. The GWAS summary data of PSC was driven from 4,796 PSC cases and 19,955 healthy controls. The eQTL datasets of CD4+ T cells, CD8+ T cells, B cells, natural killer cells (NK), monocytes, and peripheral blood cells (PB) were collected from recently eQTL study. The PSC GWAS summary dataset was first aligned with eQTL datasets of six blood cells to obtain the GWAS summary data at overlapped eQTL loci, separately. For each type of cell, the obtained PSC GWAS summary dataset of eQTLs was subjected to pathway enrichment analysis. 853 biological pathways from Kyoto Encyclopedia of Genes and Genomes, BioCarta, and Reactome pathway databases were analyzed. Results. We identified 36 pathways for B cells, 33 pathways for CD4+ T cells, 28 pathways for CD8+ T cells, 33 pathways for monocytes (MN), 35 pathways for NK cells, and 33 for PB cells (all empirical P values < 5.0 × 10 − 5 ). Comparing the pathway analysis results detected 25 pathways shared by five immune cells, such as KEGG_CELL_ADHESION_MOLECULES_CAMS ( P value < 5.0 × 10 − 5 ) and REACTOME_MHC_CLASS_II_ANTIGEN_ PRESENTATION ( P value < 5.0 × 10 − 5 ). Several cell-specific pathways were also identified, including BIOCARTA_INFLAM_PATHWAY ( P value < 5 × 10 − 5 ) for B cell. Conclusion. Our study holds potential to identify novel candidate causal pathways and provides clues for revealing the complex genetic mechanism of PSC.

show abstract